The 20 Best Lymphadenectomy Doctors near Ann Arbor, MI

Dr. Clifford S. Cho is the C. Gardner Child Professor of Surgery in the Division of Hepatopancreatobiliary and Advanced Gastrointestinal Surgery at Michigan Medicine.Dr. Cho is an Honors graduate of Brown University and AOA graduate of the Vanderbilt University School of Medicine. He completed his general surgery residency and transplantation immunology postdoctoral research fellowship at the University of Wisconsin, where he served as Chief Administrative Resident. He completed his surgical oncology fellowship at the Memorial Sloan-Kettering Cancer Center, where he served as Chief Administrative Fellow. He joined the faculty of the University of Wisconsin School of Medicine and Public Health in 2006, where he was promoted to Associate Professor with Tenure and named the Ronald and Patricia Kissinger Professor of Surgical Oncology. He served as Chief of the Division of Surgical Oncology, Associate Residency Program Director, and co-Director of the Gastrointestinal Disease Oriented Team in the University of Wisconsin Carbone Cancer Center before moving to the University of Michigan in 2016.Dr. Cho’s academic focus is on hepatopancreatobiliary and gastrointestinal malignancies, cancer immunology, and the mentorship of clinical and research trainees. He has lectured on these academic interests in over 15 national and international visiting professorships, and was named the James IV Traveler in 2014. He has published over 120 peer-reviewed manuscripts and book chapters and currently serves on the editorial boards of Surgery and the Journal of Gastrointestinal Surgery. He is the Principal Investigator of a VA Merit Review-funded cancer immunology laboratory that is working to understand cancer-induced T cell suppression, and to identify novel T cell-based strategies for cancer immunotherapy. His laboratory has been continuously funded since 2006 by extramural support from the Veteran’s Administration, National Institutes of Health, American College of Surgeons, and Central Surgical Association, and is a member of the VA Oncology Merit Review study section. He has held a number of national academic leadership positions and is a member of over 15 surgical societies, including the American Surgical Association, Society of Clinical Surgery, Society of University Surgeons, and Surgical Biology Club II. Dr. Cho is rated as an Advanced provider by MediFind in Lymphadenectomy. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Cho is board certified in Surgery.

Adeyiza O. Momoh, M.D., James W. Crudup Professor serves as a faculty member in the Section of Plastic Surgery at Michigan Medicine.Dr. Momoh received his BS in Biology from Calvin College and his M.D. degree from Northwestern University School of Medicine. He completed his plastic surgery training at the Baylor College of Medicine, Michael E. DeBakey department of surgery. Following this, he spent a year of fellowship training in microsurgical breast reconstruction and aesthetic breast surgery at the Beth Israel Deaconess Medical Center of Harvard Medical School in Boston, Massachusetts.He is a member of the American Society of Plastic Surgeons, American College of Surgeons, American Society for Reconstructive Microsurgery, Plastic Surgery Research Council, Reed O. Dingman Society, Michigan Academy of Plastic Surgeons, and American Council of Academic Surgeons.Clinical Specialization: Dr. Momoh specializes in all forms of breast reconstruction and has a particular interest in microsurgical breast reconstruction, utilizing a variety of perforator flaps such as the DIEP, SIEA and SGAP flaps. Additional areas of clinical focus include breast augmentation, breast lifts and body procedures for mothers aimed at restoration of form following pregnancy. Dr. Momoh is rated as an Advanced provider by MediFind in Lymphadenectomy. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy. Dr. Momoh is board certified in Plastic Surgery.

Dr. Lesly Dossett, MD, MPH, is the Maud T. Lane Research Professor for Cancer Quality Improvement and Chief of the Division of Surgical Oncology at the University of Michigan. Dr. Dossett earned her medical degree from Vanderbilt University School of Medicine in 2003, having attended on a United States Navy Health Professions Scholarship. She completed her general surgery residency at Vanderbilt University in 2010, which included a health services research fellowship and completion of an MPH. After residency, Dr. Dossett served on active duty with the United States Navy in several roles stateside and overseas, including completing two deployments supporting combat operations in Afghanistan. After leaving the Navy in 2014, Dr. Dossett completed a clinical fellowship in Complex General Surgical Oncology at Moffitt Cancer Center and joined the faculty of the University of Michigan in 2016.Dr. Dossett specializes in treating patients with melanoma, soft tissue sarcoma, and breast cancer. Her research leverages implementation science frameworks and behavioral strategies to improve healthcare value. As co-director of the Michigan Program for Value Enhancement (MPrOVE), she works to translate value-based research findings into practice at Michigan Medicine and then scale those strategies more broadly to hospitals and healthcare systems. She is a principal investigator for R01s funded by the National Cancer Institute (NCI) and the Agency for Healthcare Research and Quality (AHRQ). She serves as a mentor on several federally funded training grants and career development awards.Dr. Dossett is an active member of several national societies. She serves as an officer in the Association for Academic Surgeons (AAS) and in the executive leadership of the American College of Surgeons (ACS) Cancer Research Program (CRP) and the Surgical Outcomes Club.Clinical Specialization:Dr. Dossett’s clinical focus is on melanoma and non-melanoma skin cancers, sarcoma, and breast cancer. She has expertise in locally and regionally advanced melanoma, breast angiosarcoma, retroperitoneal and pelvic sarcoma, breast conservation therapy, and skin and nipple sparing mastectomy. Dr. Dossett is rated as an Experienced provider by MediFind in Lymphadenectomy. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Retroperitoneal Liposarcoma, Melanoma, Desmoplastic Small Round Cell Tumor, Mastectomy, and Lymphadenectomy. Dr. Dossett is board certified in Surgery and Complex General Surgical Oncology.

Ajjai Alva is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Alva is rated as an Experienced provider by MediFind in Lymphadenectomy. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Nephrectomy, and Lymphadenectomy.

Dr. Jeffery Montgomery's clinical interests include the diagnosis and management of bladder, prostate, and penile and testicular cancers. With his advanced training in urologic oncology and minimally invasive surgical techniques, such as robotic, laparoscopic and complex open surgery, he is able to deliver state-of-the-art care to his patients. He has expertise in state-of-the-art diagnostics for prostate cancer, including prostate MRI, fusion prostate biopsy, and transperineal standard and fusion prostate biopsies. He has extensive experience performing advanced robotic surgery, including prostatectomy, cystectomy with intra-corporeal urinary diversions, and inguinal lymph node dissections. Dr. Montgomery's research focuses on improving the quality and efficiency of urologic oncology disease management. Dr. Montgomery is a Michigan native and earned his undergraduate degree from the University of Michigan. He then went on to complete his medical education at the Columbia University College of Physicians and Surgeons in New York before finishing his Urology residency at the University of Michigan. He completed his urologic oncology fellowship at the University of Texas MD Anderson Cancer Center. Dr. Montgomery is rated as an Experienced provider by MediFind in Lymphadenectomy. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Cystectomy, and Prostatectomy. Dr. Montgomery is board certified in Urology.

Dr. Jeruss is a Professor of Surgery and the Director of the University of Michigan Breast Care Center. She also holds appointments in the Departments of Pathology and Biomedical Engineering at the University of Michigan. Dr. Jeruss received her undergraduate degree in neuroscience and history from Brandeis University and her medical degree from the University of Vermont. Dr. Jeruss completed her General Surgery residency training at Northwestern University Medical School and holds a PhD from Northwestern, having done her dissertation in the field of breast cancer biology. She completed her fellowship in Breast Surgical Oncology at M.D. Anderson Cancer Center in 2006, and returned to Northwestern as Associate Professor of Surgery in the Division of Breast Surgery before joining the University of Michigan faculty.Dr. Jeruss is board certified in General Surgery and is a member of several professional societies. Through her basic and clinical research program, Dr. Jeruss has been actively involved in the training of high school students, undergraduates, graduate students at the PhD and post-doctoral levels, medical students, and residents. She has published numerous manuscripts and book chapters, and has also received many awards for teaching and research. Dr. Jeruss is rated as an Experienced provider by MediFind in Lymphadenectomy. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy. Dr. Jeruss is board certified in Surgery.

Evan Glazer, MD, PhD, FACS, is the Clinical Director of the Pancreatic Cancer Program at Michigan Medicine and the Associate Director of Clinical Research in the Rogel and Blondy Center for Pancreatic Cancer. Dr. Glazer earned his medical degree and a master's degree in public health at the George Washington University in Washington, DC. Subsequently, he completed residency in general surgery and completed a PhD in Cancer Biology at the University of Arizona, in Tucson, AZ. Dr. Glazer completed an NIH funded T32 training fellowship at the M.D. Anderson Cancer Center in Houston, TX. He completed a fellowship in complex general surgical oncology at the H. Lee Moffitt Cancer Center in Tampa, FL. Dr. Glazer is board certified in complex general surgical oncology and general surgery. His clinical and research focuses are on pancreatic and liver malignancies.After completing fellowship in Tampa, Dr. Glazer joined the University of Tennessee Health Science Center in Memphis, TN, and rose in rank to Associate Professor. He served as program director of the complex general surgical oncology fellowship there as well as associate program director for research in the general surgery residency program. Dr. Glazer is a member of the American College of Surgeons, American Association for Cancer Research, Society of Surgical Oncology, Association of Academic Surgery, and American Society of Clinical Oncology. With a national reputation, he has served on the Hepatobiliary Panel and Pancreatic Adenocarcinoma Panel for the National Comprehensive Cancer Network. He has served numerous roles for the Society of Surgical Oncology. Dr. Glazer is rated as an Experienced provider by MediFind in Lymphadenectomy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Liver Cancer, Fibrolamellar Carcinoma, Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Glazer is board certified in Surgery and Complex General Surgical Oncology.

Alfred Chang is a General Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Chang is rated as an Experienced provider by MediFind in Lymphadenectomy. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Melanoma, Breast Cancer, Intraductal Papilloma, Mastectomy, and Lymphadenectomy.

Kelly Malloy is an Otolaryngologist and a Plastic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Malloy is rated as an Experienced provider by MediFind in Lymphadenectomy. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Laryngectomy, and Osteotomy.

David Odell is a General Surgeon and a Thoracic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Odell is rated as an Experienced provider by MediFind in Lymphadenectomy. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Lung Nodules, Non-Small Cell Lung Cancer (NSCLC), Endoscopy, and Gastrostomy.

Todd M. Morgan, M.D. is a urological surgeon specializing in the treatment of genitourinary malignancies. Dr. Morgan is originally from Seattle, WA, and completed his undergraduate and medical training at Harvard University. He returned to the Northwest in 2003 for his urology residency at the University of Washington, before moving to Nashville for his fellowship training in urological oncology at Vanderbilt University. Dr. Morgan is a translational surgeon-scientist, and his research spans the spectrum from preclinical laboratory-based research to prospective clinical trials. The primary focus of his laboratory is on identifying key pathways that predict response and resistance to treatment in genitourinary malignancies. This includes work in prostate cancer to develop liquid biopsy approaches that can guide precision-based therapeutic strategies in real time, as well as ongoing research in renal cell carcinoma to identify genomic signatures for risk stratification.Dr. Morgan is currently an Associate Professor of Urology and has been at the University of Michigan since 2012. In addition to his research pursuits, he is a busy clinician and surgeon offering advanced robotic, laparoscopic, and open surgical approaches for patients with genitourinary malignancies. He has substantial expertise in the use and interpretation of molecular biomarkers, which can help guide individualized treatment choice for some patients.Beyond work, he loves his time enjoying the great town of Ann Arbor and beautiful state of Michigan with his wife, Wendy, and their two young boys. Whether camping in Petoskey, sitting on a beach in Grand Haven, or biking around the neighborhood in Ann Arbor, the Morgan family has quickly learned that life in the Midwest is hard to beat. Dr. Morgan is rated as an Experienced provider by MediFind in Lymphadenectomy. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Muscle Invasive Bladder Cancer, Bladder Cancer, Prostatectomy, and Nephrectomy. Dr. Morgan is board certified in Urology.

Dr. Angeles is an Associate Professor with Tenure of Surgery, Associate Professor of Dermatology, and Faculty Member in the Cancer Biology PhD Program at the University of Michigan in the Division of Surgical Oncology. She earned her medical degree at Tufts University School of Medicine. She completed general surgery residency at New York Presbyterian-Weill Cornell Medical Center. While in residency she completed a two-year basic/translational science Surgical Oncology Research Fellowship at Memorial Sloan-Kettering Cancer Center (MSKCC) focusing on the molecular biology and novel therapeutics for sarcoma. After residency, Dr. Angeles returned to MSKCC and completed a clinical Complex Surgical Oncology Fellowship. Dr. Angeles is board-certified in both General Surgery and Complex General Surgical Oncology. She is the Director of the Regional Cancer Therapies Clinic at University of Michigan/Rogel Cancer Center. Dr. Angeles is a nationally recognized surgeon-scientist dedicated to advancing cancer care through innovative research and compassionate patient care. As the lead investigator for multiple clinical trials at the Rogel Cancer Center, she is at the forefront of developing new treatments for melanoma and sarcoma. Her laboratory studies the immune system’s role in fighting cancer, with a special focus on how resident memory T cells can help create long-lasting protection against tumors. By combining basic science and translational research, Dr. Angeles and her team are working to transform discoveries in the lab into effective new therapies for patients. Dr. Angeles’s research has been supported by the American Cancer Society, the Melanoma Research Alliance, the Society of Surgical Oncology, and the National Institutes of Health’s National Cancer Institute (NCI-NIH).Committed to excellence in both science and patient care, Dr. Angeles is a Fellow of the American College of Surgeons, a Fellow of the Society of Surgical Oncology, and an active member of professional societies including the American Society of Clinical Oncology (ASCO), the Society of Surgical Oncology (SSO), the Connective Tissue Oncology Society (CTOS), and the Society for Immunotherapy of Cancer (SITC). She also serves as Chair of the Society of Surgical Oncology's Research Committee, helping to shape the future of cancer research and treatment.Clinical Specialization:Dr. Angeles is a board-certified surgical oncologist whose clinical practice focuses on patients with soft tissue cancers including sarcoma, melanoma, and non-melanoma cutaneous malignancies. Dr. Angeles cares for patients in a robust multidisciplinary fashion and provides education and counseling to her patients in order to allow shared decision making for the surgical management of their disease. Dr. Angeles is rated as an Experienced provider by MediFind in Lymphadenectomy. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Melanoma, Splenectomy, and Nephrectomy. Dr. Angeles is board certified in Surgery and Complex General Surgical Oncology.

Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is rated as an Experienced provider by MediFind in Lymphadenectomy. She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology.

Dr. Lagisetty serves as an Assistant Professor of Surgery in the Section of Thoracic Surgery at the University of Michigan Health System.He is a graduate from the University of Alabama at Birmingham with a degree in Philosophy in 2003 and medical degree in 2007. His General Surgical residency was completed at Beth Israel Deaconess Medical Center/Harvard Medical School. Dr. Lagisetty spent two years as a Clinical Research Fellow at the National Institutes of Health studying tumor immunology and genetic engineering/therapy. After residency he completed a two year Thoracic Surgery Fellowship at the University of Michigan.Clinical Specialization: Dr. Lagisetty specializes in all areas of general thoracic surgery, benign and malignant esophageal disorders, benign and malignant lung resections, minimally invasive including robotic techniques, lung transplantation. Dr. Lagisetty is rated as an Experienced provider by MediFind in Lymphadenectomy. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Hiatal Hernia, Congenital Diaphragmatic Hernia, Hernia, Endoscopy, and Lung Transplant. Dr. Lagisetty is board certified in Surgery and Thoracic & Cardiac Surgery.

Simpa S. Salami, M.D., M.P.H. is a fellowship-trained, board-certified Urologic Oncologist and Associate Professor of Urology at the University of Michigan. He obtained his medical degree from the College of Medicine, University of Ibadan, Nigeria. Thereafter, he completed a Master of Public Health program at Harvard University, General Surgery Internship at the Brigham and Women’s Hospital in Boston, Urology Residency at Hofstra Northwell Health School of Medicine in New York, and Urologic Oncology Fellowship at the University of Michigan in Ann Arbor, Michigan. Dr. Salami’s clinical expertise is in the minimally invasive surgical treatment of prostate and kidney cancer. As a translational surgeon-scientist, his laboratory focuses on developing novel cancer biomarkers to overcome tumor heterogeneity and multifocality as well as elucidate optimal paradigms for early detection of urologic cancers, risk stratification, prognostication, and prediction of treatment response. Dr. Salami’s lab collaborates with investigators all over the world to understand the molecular underpinnings of urologic cancer and associated disparities. Dr. Salami is a recipient of several awards including the: Harvard University Presidential Scholar, Prostate Cancer Foundation Young Investigator, American Urological Association (AUA) Urology Care Foundation (UCF) Research Scholar, AUA UCF Rising Stars in Urologic Research, Harold Amos Medical Faculty Development Fellowship, Rogel Cancer Center Scholar, Society of Urologic Oncology Young Investigator, NCI R37 MERIT and 2024 AUA Gold Cystoscope Awards. Most recently, he was named an inaugural Biden White House Cancer Moonshot Scholar. He has served on several National guideline committees, such as the AUA Prostate Cancer Early Detection Guidelines, the NCCN Prostate Cancer Early Detection Guidelines, and the Society of Nuclear Medicine and Imaging PSMA PET Appropriate Use Criteria Working Group. His research is supported by multiple sources and includes funding from the Department of Defense, National Cancer Institute, and the Prostate Cancer Foundation. Dr. Salami is rated as an Experienced provider by MediFind in Lymphadenectomy. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Prostatectomy. Dr. Salami is board certified in Urology.

Scott Mclean is an Otolaryngologist and a Plastic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Mclean is rated as an Experienced provider by MediFind in Lymphadenectomy. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Teratocarcinosarcoma, Sinus Cancer, Tissue Biopsy, and Laryngectomy. Dr. Mclean is board certified in Otolaryngology-Head & Neck Surgery.

Andrew C. Chang, M.D., is the Cameron Haight Collegiate Professor of Thoracic Surgery at the University of Michigan. After completing his undergraduate education at the Massachusetts Institute of Technology and medical education at The Johns Hopkins University he pursued general surgical residency at Vanderbilt University. During this time he also obtained an individual National Research Service Award from the National Institutes of Health to study cardiothoracic transplantation with Richard N. Pierson, III, M.D. He then continued as a thoracic surgical resident and subsequently thoracic surgical fellow at the University of Michigan, completing these in 2003, before joining the faculty. Dr. Chang is rated as an Experienced provider by MediFind in Lymphadenectomy. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Achalasia, Hiatal Hernia, Hernia, Endoscopy, and Lung Transplant. Dr. Chang is board certified in Surgery and Thoracic & Cardiac Surgery.

Dr. Chaz Stucken is an associate professor of otolaryngology- head & neck surgery at the University of Michigan. He is dual-fellowship trained in both head & neck cancer surgery as well as facial plastic & reconstructive surgery. Dr. Stucken completed an accelerated 7-year B.A./M.D. at Boston University, earning his M.D. in 2008. He subsequently completed his training in otolaryngology-head & neck surgery at The Mount Sinai Hospital in New York City, where he received the Chairman’s Award at the completion of residency. Dr. Stucken then earned sub-specialty fellowship training in head & neck oncologic & microvascular surgery at the University of Michigan and in Facial Plastic & Reconstructive Surgery at Ohio State University. Throughout his training, Dr. Stucken received awards for excellence in research and clinical care. He has published several book chapters and scholarly articles in otolaryngology texts and peer-reviewed journals. Dr. Stucken is involved in humanitarian outreach work and has traveled to Guatemala to perform cleft lip surgery. He is dedicated to serving Spanish-speaking patients in southeast Michigan. He has given numerous presentations at conferences around the country, taught at instructional courses for other surgeons, and has been an invited faculty member to symposium on facial plastic & reconstructive surgery. He is an active member of the American Academy of Otolaryngology- Head & Neck Surgery and the American Academy of Facial Plastic & Reconstructive Surgery. He serves on several national committees including the Plastic & Reconstructive Surgery Committee, Microvascular Surgery Committee, and Humanitarian Efforts Committee.Dr. Stucken is committed to providing the highest level of care to his patients. He is also working to discover medical and surgical breakthroughs by collaborating with other surgeons and researchers throughout the medical center. He works closely with cutaneous oncology surgeons to provide optimal skin cancer treatments and reconstruction. As a member of the Comprehensive Head & Neck Cancer Team, he works closely with medical oncologists and radiation oncologists and enrolls patients in the most advanced clinical trials. Surgically, his subspecialty training gives him the opportunity to provide specialized care for every patient in order to obtain the best possible outcomes. Dr. Stucken is rated as an Experienced provider by MediFind in Lymphadenectomy. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Melanoma, Laryngectomy, and Tissue Biopsy. Dr. Stucken is board certified in Otolaryngology-Head & Neck Surgery and Facial Plastic & Recon Surg.

Darren King is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 18 years. Dr. King is rated as an Experienced provider by MediFind in Lymphadenectomy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. King is board certified in Hematology and Medical Oncology.

Dr. Tasha Hughes is a Clinical Associate Professor of Surgery and a surgical oncologist at the University of Michigan. Her clinical efforts are focused on the treatment of breast cancer and melanoma. She is a health services research with a program centered around provider communication, provider bias and health care safety and quality.Dr. Hughes completed her surgical oncology training at Ohio State University Wexner Medical Center and James Comprehensive Cancer Society and her residency at Rush University Medical Center and John H. Stroger Hospital of Cook County in Chicago, IL. Dr. Hughes is rated as an Experienced provider by MediFind in Lymphadenectomy. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Lymphadenectomy.